InterVenn Biosciences: Tillman Pearce, Klaus Lindpaintner
Jan 24, 2022
Tillman Pearce has been appointed as chief medical officer of InterVenn Biosciences. He replaces Klaus Lindpaintner, who held the role of chief medical and chief scientific officer and has become distinguished scientist, a new role at the firm. Pearce joins InterVenn from OBI Pharmaceuticals, where he was chief medical officer. He holds an MD from Medical College of Georgia.